Merit Financial Group, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1621225 ALPHARETTA, GA

Position in VRTX

as of Mar 31, 2026 · filed Apr 15, 2026 Compact

Position Value

$4,614,987

+$549,714 QoQ

Shares Held

10,335

+15.3% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0.05805515239477503.ToString("F0")% Shared 0.ToString("F0")% None 99.94194484760523.ToString("F0")%

Healthcare · as of Mar 31, 2026

Merit Financial Group, LLC holds $40,595,069 across 47 Biotechnology names. VRTX ranks #3 (11.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	318,113	$13,643,864
2	INCY	Incyte Corp	49,484	$4,657,432
3	VRTX	Vertex Pharmaceuticals Inc / Ma This page	10,335	$4,614,987
4	REGN	Regeneron Pharmaceuticals, Inc.	5,585	$4,315,191
5	BMRN	Biomarin Pharmaceutical Inc	30,594	$1,728,254
6	ALNY	Alnylam Pharmaceuticals, Inc.	2,903	$960,514
7	ACAD	Acadia Pharmaceuticals Inc	38,999	$868,116
8	JAZZ	Jazz Pharmaceuticals plc	4,077	$770,755

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,614,987	10,335	+15.3%	Shares	Other	2026-04-15
2025-12-31	$4,065,273	8,967	+47.3%	Shares	Other	2026-01-26
2025-09-30	$2,383,909	6,087	-2.8%	Shares	Other	2025-11-07
2025-06-30	$2,786,952	6,260	+15.3%	Shares	Sole	2025-07-22
2025-03-31	$2,631,118	5,427	+10.1%	Shares	Sole	2025-04-09
2024-12-31	$1,985,713	4,931	+77.6%	Shares	Sole	2025-01-15
2024-09-30	$1,291,062	2,776	-26.5%	Shares	Sole	2024-10-17
2024-06-30	$1,770,355	3,777	+10.0%	Shares	Sole	2024-08-13
2024-03-31	$1,435,864	3,435	+75.4%	Shares	Sole	2024-05-06
2023-12-31	$796,690	1,958	-46.4%	Shares	Sole	2024-02-06
2023-09-30	$1,271,337	3,656	-7.0%	Shares	Sole	2023-11-07
2023-06-30	$1,383,358	3,931	+140.6%	Shares	Sole	2023-08-01
2023-03-31	$514,824	1,634	—	Shares	Sole	2023-04-24
No filing history on record for this holder in this stock.